Equitable Trust’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,138
| Closed | -$211K | – | 491 |
|
|
2024
Q3 | $211K | Buy |
+2,138
| New | +$211K | 0.01% | 433 |
|
|
2024
Q2 | – | Sell |
-2,138
| Closed | -$203K | – | 452 |
|
|
2024
Q1 | $203K | Buy |
+2,138
| New | +$203K | 0.01% | 418 |
|
|
2023
Q1 | – | Sell |
-2,467
| Closed | -$205K | – | 411 |
|
|
2022
Q4 | $205K | Sell |
2,467
-18,101
| -88% | -$1.5M | 0.02% | 377 |
|
|
2022
Q3 | $1.63M | Sell |
20,568
-277
| -1% | -$22K | 0.14% | 135 |
|
|
2022
Q2 | $1.55M | Sell |
20,845
-87,474
| -81% | -$6.5M | 0.12% | 146 |
|
|
2022
Q1 | $9.74M | Buy |
108,319
+105,728
| +4,081% | +$9.5M | 0.63% | 39 |
|
|
2021
Q4 | $290K | Sell |
2,591
-1,446
| -36% | -$162K | 0.02% | 321 |
|
|
2021
Q3 | $507K | Hold |
4,037
| – | – | 0.03% | 241 |
|
|
2021
Q2 | $547K | Sell |
4,037
-577
| -13% | -$78.2K | 0.04% | 238 |
|
|
2021
Q1 | $626K | Hold |
4,614
| – | – | 0.05% | 218 |
|
|
2020
Q4 | $650K | Buy |
4,614
+83
| +2% | +$11.7K | 0.05% | 225 |
|
|
2020
Q3 | $505K | Buy |
4,531
+500
| +12% | +$55.7K | 0.04% | 233 |
|
|
2020
Q2 | $451K | Buy |
4,031
+205
| +5% | +$22.9K | 0.04% | 226 |
|
|
2020
Q1 | $296K | Buy |
3,826
+35
| +0.9% | +$2.71K | 0.03% | 255 |
|
|
2019
Q4 | $361K | Sell |
3,791
-418
| -10% | -$39.8K | 0.04% | 226 |
|
|
2019
Q3 | $321K | Sell |
4,209
-70
| -2% | -$5.34K | 0.03% | 233 |
|
|
2019
Q2 | $375K | Sell |
4,279
-696
| -14% | -$61K | 0.04% | 214 |
|
|
2019
Q1 | $450K | Sell |
4,975
-146
| -3% | -$13.2K | 0.05% | 204 |
|
|
2018
Q4 | $367K | Buy |
5,121
+129
| +3% | +$9.25K | 0.05% | 204 |
|
|
2018
Q3 | $479K | Sell |
4,992
-200
| -4% | -$19.2K | 0.06% | 206 |
|
|
2018
Q2 | $494K | Buy |
+5,192
| New | +$494K | 0.06% | 187 |
|